Cochlear sales recover but Covid-19 risks remain high
Hearing implant manufacturer Cochlear has regained some of the massive slump in business as implant surgeries were cancelled due to the Covid-19 pandemic, but the company cautions business risks remain high. In a first quarter trading update, Cochlear told investors that cochlear implant or bionic ear revenue in the quarter was 94 per cent of…